Table 1 Demographics and clinical characteristics of patients with lupus nephritis and healthy controls
From: Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
Parameters | lupus nephritis | healthy controls | P value |
|---|---|---|---|
n | 101 | 21 | – |
Female, n (%) | 82 (81.2%) | 14 (66.7%) | 0.14a |
Age, median (IQR), years | 29.0 (24.0–38.0) | 31.0 (27.5–39.5) | 0.15b |
Mean arterial pressure, mean (SEM), mmHg | 97.8 (1.4) | 91.7 (1.5) | < 0.01c |
LN duration, median (IQR), years | 0.3 (0.1–1.4) | – | – |
SLEDAI-2 k, mean (SEM) | 17.8 (0.6) | – | – |
Renal SLEDAI, median (IQR) | 12.0 (8.0–16.0) | – | – |
AI score, median (IQR) | 5.0 (4.0–7.0) | – | – |
CI score, median (IQR) | 4.0 (3.0–5.0) | – | – |
24-h urine protein, median (IQR), g | 2.5 (1.0–7.0) | – | – |
Hemoglobin, mean (SEM), g/L | 108.5 (2.0) | – | – |
Serum albumin, mean (SEM), g/L | 26.9 (0.8) | – | |
Serum creatinine, median (IQR), μmol/L | 70.0 (56.0–99.8) | – | – |
Blood urea nitrogen, median (IQR), mmol/L | 6.3 (4.5–8.2) | – | – |
Uric acid, median (IQR), μmol/L | 342.5 (273.5–418.8) | – | – |
Blood phosphorus, median (IQR), mmol/L | 1.2 (1.1–1.4) | – | – |
Complement 3, median (IQR), g/L | 0.4 (0.3–0.6) | – | – |
Complement 4, median (IQR), g/L | 0.07 (0.04–0.1) | – | – |